ClarusC64/clinical-quad-biomarker-subpopulation-dosing-endpoint-drift-v0.1 Viewer • Updated Feb 21 • 10 • 30
ClarusC64/clinical-quad-immunogenicity-dosing-interval-antibody-efficacy-decay-v0.1 Viewer • Updated Feb 21 • 10 • 14